Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Shoulder Innovations reported engagement with 342 surgeons and other clinicians in the states MedaRep covers, worth $1.9M in consulting, speaking, meals and travel for its device products, the most in California ($361K to 52). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($361K, 52 engaged), Michigan ($194K, 8 engaged), Connecticut ($190K, 6 engaged), Ohio ($169K, 11 engaged), Maryland ($122K, 5 engaged).
In the last ten years FDA made 8 decisions for Shoulder Innovations (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2026 (3). The latest was on 2026-09-08.
| InSet Total Shoulder System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Shoulder Innovations.